Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2016 Sep 9:6:33045.
doi: 10.1038/srep33045.

Raman-based detection of hydroxyethyl starch in kidney allograft biopsies as a potential marker of allograft quality in kidney transplant recipients

Affiliations
Clinical Trial

Raman-based detection of hydroxyethyl starch in kidney allograft biopsies as a potential marker of allograft quality in kidney transplant recipients

Vincent Vuiblet et al. Sci Rep. .

Abstract

In brain-dead donor resuscitation, hydroxyethyl starch (HES) use has been associated with presence of osmotic-nephrosis-like lesions in kidney transplant recipients. Our aim was to determine whether the presence of HES in protocol renal graft biopsies at three months (M3) after transplantation is associated with renal graft quality. According to the HES administered to the donor during the procurement procedure, two groups of patients were defined according graft exposition to HES: HES group, (N = 20) and control group (N = 6). Detection and relative quantification of HES was performed by Raman spectroscopy microimaging on M3 protocol renal graft biopsies. Statistical analyses were used to investigate the association between Raman data and graft characteristics. HES spectral signal was revealed negative in the control group, whereas it was positive in 40% of biopsies from the HES group. In the HES group, a stronger HES signal was associated with a lower risk of graft failure measured by the Kidney Donor Risk Index (KDRI) and was correlated with the allograft kidney function. Thus, HES accumulation in donor kidney, as probed by Raman biophotonic technique, is correlated with the quality of donor kidney and consequently the graft renal function and graft survival.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flow chart of the study design.
Figure 2
Figure 2. Raman image together with extracted Raman spectra originated from a M3 graft biopsy from the HES group.
(A) Masson trichrome stained section from paraffin-embedded biopsy depicting a renal tubular sections area (x20) (B) 10 μm-thick cryosection of renal graft biopsy observed under white light without staining. Red frame corresponds to the region of interest selected for Raman analysis; red points correspond to spots of Raman measurements (C) Raman image constructed from the integrated intensity on the whole fingerprint spectral range. Color scale: yellow to red corresponding to low to high intensity (D) Spectrum extracted from one pixel (pointed by the blue arrow) (E) Spectra extracted from the selected ROI (red frame).
Figure 3
Figure 3
Relationship between HES spectral signal (arbitrary unit; a.u.) and (A) the Kidney Donor Risk index (KDRI) (r = −0.72; p < 0.001) and (B) estimated glomerular filtration rate at 3 months (eGFR at M3 in ml/min/1.73 m2) (r = 0.88, p < 0.001).

Similar articles

Cited by

References

    1. Malinoski D. J. et al.. The impact of meeting donor management goals on the development of delayed graft function in kidney transplant recipients. Am J Transplant 13, 993–1000 (2013). - PubMed
    1. Malinoski D. J., Patel M. S., Daly M. C., Oley-Graybill C. & Salim A. The impact of meeting donor management goals on the number of organs transplanted per donor: results from the United Network for Organ Sharing Region 5 prospective donor management goals study. Critical care medicine 40, 2773–2780 (2012). - PubMed
    1. Shemie S. D. et al.. Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential. Cmaj 174, S13–32 (2006). - PMC - PubMed
    1. Brunkhorst F. M. et al.. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. The New England journal of medicine 358, 125–139, doi: 10.1056/NEJMoa070716 (2008). - DOI - PubMed
    1. Schortgen F. et al.. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357, 911–916, doi: 10.1016/s0140-6736(00)04211-2 (2001). - DOI - PubMed

Publication types

Substances